Source analysis of spontaneous magnetoencephalograpic activity in healthy aging and mild cognitive impairment: influence of apolipoprotein E polymorphism.

The apolipoprotein E (APOE) ε4 allele is a genetic risk factor for the development of late-onset Alzheimer's disease (AD), which affects cholinergic system functioning. The association between reduced cholinergic levels and increase of magnetoencephalographic (MEG) low-frequency has been used to explain spectral changes found in AD patients. However, the investigation in predementia stages is scarce. We obtained MEG recordings from 25 aged controls and 36 mild cognitive impairment (MCI) patients during a resting-state condition. According to their APOE genotype, MCIs and controls were subdivided in carriers and non-carriers of the ε4 allele. Sources of spectral variations in these groups were calculated through beamforming. MCI patients exhibited a significant increase of relative power within the low-frequency domain, accompanied by a power decrease within the high-frequency range. APOEε4 carriers showed an increased relative power in the 4.5-6.5 Hz frequency range over frontal lobes. The power increase observed in controls carrying ε4 was significantly higher as compared with MCI non-carriers, while MCI carriers exhibited the highest relative power within the 4.5-6.5 Hz range. Higher power values within the low-frequency ranges correlated with a poorer cognitive performance in MCIs and controls. Our investigation demonstrates that APOEε4 affects resting-state activity to an extent that makes it more proximate to the pattern observed in early stages of AD. Therefore, a combination of genetic and neurophysiological information might help to detect MCI patients at higher risk of conversion to AD, and asymptomatic subjects at higher risk of developing a manifest cognitive deterioration.

[1]  Roberto Hornero,et al.  Quantitative Magnetoencephalography of Spontaneous Brain Activity in Alzheimer Disease: An Exhaustive Frequency Analysis , 2006, Alzheimer disease and associated disorders.

[2]  Werner Lutzenberger,et al.  Fractal dimension of electroencephalographic time series and underlying brain processes , 1995, Biological Cybernetics.

[3]  P Gloor,et al.  Brain lesions that produce delta waves in the EEG , 1977, Neurology.

[4]  M. D. Ernst.  Permutation Methods: A Basis for Exact Inference , 2004 .

[5]  R. Katzman.,et al.  Pathological verification of ischemic score in differentiation of dementias , 1980, Annals of neurology.

[6]  Roberto Hornero,et al.  MEG spectral profile in Alzheimer's disease and mild cognitive impairment , 2006, Clinical Neurophysiology.

[7]  C. Babiloni,et al.  Conversion from mild cognitive impairment to Alzheimer’s disease is predicted by sources and coherence of brain electroencephalography rhythms , 2006, Neuroscience.

[8]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[9]  T. Kurosaki,et al.  Measurement of functional activities in older adults in the community. , 1982, Journal of gerontology.

[10]  Keith A. Johnson,et al.  Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease , 2013, Neurobiology of Aging.

[11]  G L Shulman,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .

[12]  A. Fagan,et al.  APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging , 2010, Annals of neurology.

[13]  P. Rossini,et al.  Cortical sources of resting EEG rhythms in mild cognitive impairment and subjective memory complaint , 2010, Neurobiology of Aging.

[14]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[15]  G. Alexander,et al.  Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism , 2005 .

[16]  Robert Oostenveld,et al.  FieldTrip: Open Source Software for Advanced Analysis of MEG, EEG, and Invasive Electrophysiological Data , 2010, Comput. Intell. Neurosci..

[17]  Mathew Varghese,et al.  Apolipoprotein E4 and Brain White Matter Integrity in Alzheimer’s Disease: Tract-Based Spatial Statistics Study under 3-Tesla MRI , 2012, Neurodegenerative Diseases.

[18]  Margaret A. Pericak-Vance,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease , 1997 .

[19]  Richard J. Caselli,et al.  Correlations Between Apolipoprotein E ε4 Gene Dose and Whole Brain Atrophy Rates , 2007 .

[20]  M. Pericak-Vance,et al.  Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease , 1996, The Lancet.

[21]  L. Curtiss,et al.  Apolipoprotein E and atherosclerosis. , 2000, Current opinion in lipidology.

[22]  R. Oostenveld,et al.  Nonparametric statistical testing of EEG- and MEG-data , 2007, Journal of Neuroscience Methods.

[23]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[24]  A. Barabash,et al.  APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease , 2009, Neurobiology of Aging.

[25]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[26]  J. Sirviö,et al.  Relationship between the cortical choline acetyltransferase content and EEG delta-power , 1990, Neuroscience Research.

[27]  Claudio Babiloni,et al.  Electroencephalographic Rhythms in Alzheimer's Disease , 2011, International journal of Alzheimer's disease.

[28]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[29]  Yaakov Stern,et al.  Memory performance in healthy elderly without Alzheimer’s disease: effects of time and apolipoprotein-E , 2001, Neurobiology of Aging.

[30]  G. Nolte.  The magnetic lead field theorem in the quasi-static approximation and its use for magnetoencephalography forward calculation in realistic volume conductors. , 2003, Physics in medicine and biology.

[31]  J. G. van Dijk,et al.  EEG correlates in the spectrum of cognitive decline , 2007, Clinical Neurophysiology.

[32]  W. Drongelen,et al.  Localization of brain electrical activity via linearly constrained minimum variance spatial filtering , 1997, IEEE Transactions on Biomedical Engineering.

[33]  Xianlin Han.  Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer’s disease: a tale of shotgun lipidomics , 2007, Journal of neurochemistry.

[34]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[35]  C. Jack,et al.  Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. , 2004, Archives of neurology.

[36]  R. C. Oldfield.  The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.

[37]  R. Bajo,et al.  MEG spectral analysis in subtypes of mild cognitive impairment , 2014, AGE.

[38]  A. Nordberg,et al.  Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer’s disease , 2000, Neurobiology of Aging.

[39]  S. Rombouts,et al.  Consistent resting-state networks across healthy subjects , 2006, Proceedings of the National Academy of Sciences.

[40]  R. Zivin,et al.  Apolipoprotein E Protects against NMDA Excitotoxicity , 2002, Neurobiology of Disease.

[41]  S. Anoop,et al.  Apolipoprotein E polymorphism in cerebrovascular & coronary heart diseases. , 2010, The Indian journal of medical research.

[42]  Alberto Fernández,et al.  Correlations of hippocampal atrophy and focal low-frequency magnetic activity in Alzheimer disease: volumetric MR imaging-magnetoencephalographic study. , 2003, AJNR. American journal of neuroradiology.

[43]  A. Lobo,et al.  [Cognocitive mini-test (a simple practical test to detect intellectual changes in medical patients)]. , 1979, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines.

[44]  Arto Mannermaa,et al.  A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein ε4 allele , 1995, Neuroscience Letters.

[45]  Raul Vicente,et al.  Brain-wide slowing of spontaneous alpha rhythms in mild cognitive impairment , 2013, Front. Aging Neurosci..

[46]  E. Rogaev,et al.  Age- and genotype-related neurophysiologic reactivity to oxidative stress in healthy adults , 2012, Neurobiology of Aging.

[47]  G. Alexander,et al.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Juhani Partanen,et al.  A Longitudinal Quantitative EEG Study of Alzheimer’s Disease: Relation to Apolipoprotein E Polymorphism , 2000, Dementia and Geriatric Cognitive Disorders.

[49]  H. Soininen,et al.  A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele. , 1995, Neuroscience letters.

[50]  R. Knight,et al.  The functional role of cross-frequency coupling , 2010, Trends in Cognitive Sciences.

[51]  B. Rockstroh,et al.  Focal temporoparietal slow activity in Alzheimer’s disease revealed by magnetoencephalography , 2002, Biological Psychiatry.

[52]  Daniel Bandy,et al.  Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele. , 2010, Archives of neurology.

[53]  B. Hyman,et al.  Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.

[54]  R. Fields,et al.  White matter in learning, cognition and psychiatric disorders , 2008, Trends in Neurosciences.

[55]  S. Taulu,et al.  Presentation of electromagnetic multichannel data: The signal space separation method , 2005 .

[56]  G. Buzsáki,et al.  The cholinergic system and EEG slow waves. , 1991, Electroencephalography and clinical neurophysiology.

[57]  O Almkvist,et al.  Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment. , 1996, Dementia.

[58]  J. Morris,et al.  Loss of Intranetwork and Internetwork Resting State Functional Connections with Alzheimer's Disease Progression , 2012, The Journal of Neuroscience.

[59]  B. Reisberg,et al.  The GDS/FAST Staging System , 1997, International Psychogeriatrics.

[60]  A D Roses,et al.  Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Daniel Bandy,et al.  Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. , 2007, The American journal of psychiatry.

[62]  M. Lawton,et al.  Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living , 1969 .

[63]  Claudio Del Percio,et al.  Sources of cortical rhythms change as a function of cognitive impairment in pathological aging: a multicenter study , 2006, Clinical Neurophysiology.

[64]  R. C. Oldfield.  THE ASSESSMENT AND ANALYSIS OF HANDEDNESS , 1971 .

[65]  D. Michaelson,et al.  Specific neurochemical derangements of brain projecting neurons in apolipoprotein E-deficient mice , 1997, Neuroscience Letters.

[66]  G. Glover,et al.  Dissociable Intrinsic Connectivity Networks for Salience Processing and Executive Control , 2007, The Journal of Neuroscience.

[67]  B. Reisberg,et al.  The Global Deterioration Scale for assessment of primary degenerative dementia. , 1982, The American journal of psychiatry.

[68]  Claudio Babiloni,et al.  Resting state cortical electroencephalographic rhythms are related to gray matter volume in subjects with mild cognitive impairment and Alzheimer's disease , 2013, Human brain mapping.

[69]  Juhani Partanen,et al.  Spectral analysis of EEG in Alzheimer's disease: Relation to apolipoprotein E polymorphism , 1996, Neurobiology of Aging.

[70]  R. Mayeux,et al.  Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia. , 2010, Journal of Alzheimer's disease : JAD.

[71]  R. Honea,et al.  Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. , 2009, Journal of Alzheimer's disease : JAD.

[72]  Claudio Babiloni,et al.  Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: A multicentric Electroencephalogram study , 2006, Annals of neurology.

[73]  H. Soininen,et al.  Longitudinal EEG spectral analysis in early stage of Alzheimer's disease. , 1989, Electroencephalography and clinical neurophysiology.

[74]  N. Schuff,et al.  Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study , 2010, Neurobiology of Aging.

[75]  P. Murali Doraiswamy,et al.  Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth , 2013, NeuroImage.

[76]  A D Roses,et al.  Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. , 1998, The New England journal of medicine.

[77]  P Julin,et al.  Apolipoprotein E ε4 allele decreases functional connectivity in Alzheimer’s disease as measured by EEG coherence , 1997, Journal of neurology, neurosurgery, and psychiatry.

[78]  C. Stam,et al.  Alzheimer's disease patients not carrying the apolipoprotein E ε4 allele show more severe slowing of oscillatory brain activity , 2013, Neurobiology of Aging.

[79]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[80]  S. Gauthier,et al.  Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.